BVF PARTNERS L P/IL Insider Trading $AVGN AVIGEN INC \DE
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in CURIS INC ($CRIS) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
BVF PARTNERS L P/IL in AVIGEN INC \DE
Trading Symbol: AVGNIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 8,310,015 shares
Latest Transaction: Nov 20 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in AVIGEN INC \DE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARQL, AVGN, CRIS, DVAX, CRXX, LGND, NBIX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 18,000 | 13,489 | 8,310,015 | 8.3 M to 8.3 M (+0.22 %) |
Nov 20 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 5,000 | 3,747 | 8,292,015 | 8.3 M to 8.3 M (+0.06 %) |
Nov 20 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 7,300 | 5,471 | 8,287,015 | 8.3 M to 8.3 M (+0.09 %) |
Nov 20 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 24,000 | 17,652 | 8,279,715 | 8.3 M to 8.3 M (+0.29 %) |
Nov 20 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 7,000 | 5,149 | 8,255,715 | 8.2 M to 8.3 M (+0.08 %) |
Nov 20 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 97,000 | 71,344 | 8,248,715 | 8.2 M to 8.2 M (+1.19 %) |
Nov 17 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 16,000 | 11,965 | 8,239,015 | 8.2 M to 8.2 M (+0.19 %) |
Nov 17 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 4,000 | 2,991 | 8,223,015 | 8.2 M to 8.2 M (+0.05 %) |
Nov 17 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 6,500 | 4,861 | 8,219,015 | 8.2 M to 8.2 M (+0.08 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 49,000 | 36,730 | 8,212,515 | 8.2 M to 8.2 M (+0.60 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 14,000 | 10,494 | 8,163,515 | 8.1 M to 8.2 M (+0.17 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 19,000 | 14,242 | 8,149,515 | 8.1 M to 8.1 M (+0.23 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 45,000 | 33,143 | 8,130,515 | 8.1 M to 8.1 M (+0.56 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 12,000 | 8,838 | 8,085,515 | 8.1 M to 8.1 M (+0.15 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 18,200 | 13,404 | 8,073,515 | 8.1 M to 8.1 M (+0.23 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.73 | 87,000 | 63,762 | 8,055,315 | 8 M to 8.1 M (+1.09 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.73 | 24,000 | 17,590 | 8,055,315 | 8 M to 8.1 M (+0.30 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.73 | 34,400 | 25,212 | 7,944,315 | 7.9 M to 7.9 M (+0.43 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 49,000 | 36,730 | 8,212,515 | 8.2 M to 8.2 M (+0.60 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 14,000 | 10,494 | 8,163,515 | 8.1 M to 8.2 M (+0.17 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.75 | 19,000 | 14,242 | 8,149,515 | 8.1 M to 8.1 M (+0.23 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 45,000 | 33,143 | 8,130,515 | 8.1 M to 8.1 M (+0.56 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 12,000 | 8,838 | 8,085,515 | 8.1 M to 8.1 M (+0.15 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.74 | 18,200 | 13,404 | 8,073,515 | 8.1 M to 8.1 M (+0.23 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.73 | 87,000 | 63,762 | 8,055,315 | 8 M to 8.1 M (+1.09 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.73 | 24,000 | 17,590 | 8,055,315 | 8 M to 8.1 M (+0.30 %) |
Nov 13 2008 | AVGN | AVIGEN INC \DE | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 0.73 | 34,400 | 25,212 | 7,944,315 | 7.9 M to 7.9 M (+0.43 %) |
Page: 1